Found: 77
Select item for more details and to access through your institution.
Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 750, doi. 10.1007/s10637-016-0381-4
- By:
- Publication type:
- Article
A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 2026, doi. 10.1007/s10637-011-9779-1
- By:
- Publication type:
- Article
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1621, doi. 10.1007/s10637-011-9709-2
- By:
- Publication type:
- Article
Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 8, p. 1805, doi. 10.1007/s00520-011-1278-6
- By:
- Publication type:
- Article
Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 607, doi. 10.1002/ajh.25043
- By:
- Publication type:
- Article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 4, p. 479, doi. 10.1002/(SICI)1097-0215(19960208)65:4<479::AID-IJC15>3.0.CO;2-5
- By:
- Publication type:
- Article
Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 1, p. 70, doi. 10.1002/ijc.2910620114
- By:
- Publication type:
- Article
Direct tumorigenic conversion of human gallbladder carcinoma cells by v- src but not by activated c-H- ras oncogene.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 2, p. 206, doi. 10.1002/ijc.2910610211
- By:
- Publication type:
- Article
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
- By:
- Publication type:
- Article
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patients.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/ l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 3, p. 287, doi. 10.1007/s12325-012-0002-3
- By:
- Publication type:
- Article
Characterization of a newly established human gallbladder carcinoma cell line.
- Published in:
- 1994
- By:
- Publication type:
- Letter
Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 chinese hamster cells.
- Published in:
- In Vitro Cellular & Developmental Biology Animal, 1993, v. 29, n. 4, p. 332, doi. 10.1007/BF02633962
- By:
- Publication type:
- Article
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 1, p. 132, doi. 10.1007/s10120-022-01349-y
- By:
- Publication type:
- Article
Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 5, p. 988, doi. 10.1007/s10120-019-00930-2
- By:
- Publication type:
- Article
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 817, doi. 10.1007/s10120-018-0903-1
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 1, p. 155, doi. 10.1007/s10120-018-0838-6
- By:
- Publication type:
- Article
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 464, doi. 10.1007/s10120-017-0759-9
- By:
- Publication type:
- Article
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 927, doi. 10.1007/s10120-015-0559-z
- By:
- Publication type:
- Article
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 72, doi. 10.1007/s10120-011-0009-5
- By:
- Publication type:
- Article
Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 719, doi. 10.1159/000507814
- By:
- Publication type:
- Article
Aromatase inhibitors with or without luteinizing hormone-releasing hormone agonist for metastatic male breast cancer: report of four cases and review of the literature.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 6, p. 945, doi. 10.1007/s12282-016-0679-2
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 842, doi. 10.1007/s10147-020-01631-y
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 508, doi. 10.1007/s10147-018-01391-w
- By:
- Publication type:
- Article
Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 5, p. 397, doi. 10.1007/s10147-009-0883-6
- By:
- Publication type:
- Article
NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2841, doi. 10.1007/s00432-022-04064-4
- By:
- Publication type:
- Article
A 10‐Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI‐CGA‐10) in Older Adults with Cancer: Development and Construct Validation.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1751, doi. 10.1002/onco.13894
- By:
- Publication type:
- Article
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 7, doi. 10.1634/theoncologist.2017-0275
- By:
- Publication type:
- Article
Comprehensive geriatric assessment: Valuation and patient preferences in older Japanese adults with cancer.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 1, p. 259, doi. 10.1111/jgs.18023
- By:
- Publication type:
- Article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase 3 non-inferiority study of 5-FU/ l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 1, p. 153, doi. 10.1007/s00432-014-1783-3
- By:
- Publication type:
- Article
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18702, doi. 10.1002/cam4.6486
- By:
- Publication type:
- Article
Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study)
- Published in:
- Medical Oncology, 2012, v. 29, n. 4, p. 2842, doi. 10.1007/s12032-011-0151-2
- By:
- Publication type:
- Article
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50026-4
- By:
- Publication type:
- Article
A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 11, p. 1080, doi. 10.1093/jjco/hyt127
- By:
- Publication type:
- Article
Burden on Oncologists When Communicating the Discontinuation of Anticancer Treatment.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 8, p. 999, doi. 10.1093/jjco/hyr092
- By:
- Publication type:
- Article
A Multicenter Phase-II Study of 5-FU, Leucovorin and Oxaliplatin (FOLFOX6) in Patients with Pretreated Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 63, doi. 10.1093/jjco/hyq158
- By:
- Publication type:
- Article
multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1416, doi. 10.1093/jjco/hyac143
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 248, doi. 10.1093/jjco/hyv184
- By:
- Publication type:
- Article
Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5172, doi. 10.3390/cancers15215172
- By:
- Publication type:
- Article
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7).
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 805, doi. 10.3390/cancers13040805
- By:
- Publication type:
- Article
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1175-3
- By:
- Publication type:
- Article
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article